--- title: IMAX Corporation Reports Second Quarter 2020 Results publisher: "IMAX" description: "NEW YORK , July 28, 2020 /PRNewswire/ --       HIGHLIGHTS 409 IMAX® theaters reopened in China over the July 24th weekend. The Company now has 624 theaters or approximately 40% of its global network generating revenue and is ready to benefit from an IMAX-friendly slate A strong balance sheet, with" canonical: "https://www.imax.com/pr/imax-corporation-reports-second-quarter-2020-results" date: 2020-07-28 last_updated: 2020-07-28 --- IMAX Corporation Reports Second Quarter 2020 Results ==================================================== Tue, Jul 28, 2020 NEW YORK, July 28, 2020/PRNewswire/ --     [![IMAX Logo. (PRNewsFoto/IMAX Corporation)](https://mma.prnewswire.com/media/74988/imax_corporation_logo.jpg "IMAX Logo. (PRNewsFoto/IMAX Corporation)")](https://mma.prnewswire.com/media/74988/imax_corporation_logo.html) HIGHLIGHTS * 409 IMAX® theaters reopened in Chinaover the July 24thweekend. The Company now has 624 theaters or approximately 40% of its global network generating revenue and is ready to benefit from an IMAX-friendly slate * A strong balance sheet, with $319 millionin consolidated cash as of June 30, 2020, and an amended credit agreement, with covenant flexibilty through Q3 2021, positions the Company well to manage through the ongoing COVID-19 related challenges * Cost reduction measures taken at the outset of the pandemic reduced the Company's average monthly cash burn to approximately $10 million, as demonstrated by the second quarter and in line with previous guidance * IMAX signed agreements to add 29 theater systems, headlined by the international 17-theater CGV and 10-theater Wanda deals, demonstrating continued global demand for _The_ IMAX_Experience_® from existing partners in established markets * As a result of the global pandemic, second quarter 2020 revenue decreased 92% versus 2019 to $8.9 million. Second quarter 2020 net (loss) attributable to common shareholders was ($26) million. Non-GAAP adjusted EBITDA (loss) was ($18.5) millionversus $41.4 millionin the prior-year period **Three Months Ended** **June 30,** _In thousands except per share data_ **2020** **2019** **YoY % ****Change** Total Revenue $ 8.9 $ 104.8 (91.6) % (Margin Loss) Gross Margin $ (7.7) $ 59.6 (112.9) % (Margin Loss) Gross Margin (%) (86.8) % 56.8 % Net (Loss) income attributable to common shareholders $ (26.0) $ 11.4 N/A Diluted Net (Loss) income per share attributable to common shareholders $ (0.44) $ 0.19 N/A Adjusted Net (Loss) Income(1) $ (26.1) $ 19.7 N/A Adj. Net (Loss) Income Per Share(1) $ (0.44) $ 0.32 N/A Adjusted EBITDA per Credit Facility attributable to common shareholders(1) $ (18.5) $ 41.4 N/A Adj. EBITDA Margin attributable to common shareholders (%) (1) (219.3) % 43.8 % N/A \_\_\_\_\_\_\_\_\_\_\_\_\_ (1)  Non-GAAP Financial Measure Note: For the definition and reconciliations of reported results to non-GAAP financial results, please refer to the discussion of non-GAAP financial measures at the end of this earnings release. IMAX Corporation(NYSE:IMAX) today reported second quarter 2020 revenues of $8.9 million, gross margin (loss) of ($7.7) million, and a net (loss) attributable to common shareholders of ($26.0) million, or ($0.44) per diluted share. For reconciliations of reported results to non-GAAP financial results, please see the end of this press release. Results in the second quarter reflect the closure of substantially all of the theaters in the Company's global network driven by the Coronavirus pandemic. These closures reduced IMAX Technology Network and IMAX Maintenance revenue to essentially zero and caused a margin loss for the quarter. During the second quarter, the Company accrued $3.2 millionin payroll subsidies and tax credits from the Canadian and US governments as part of their COVID-19 relief programs which benefitted SG&A expense, cost of sales, and R&D expense. "As the only global theatrical platform for blockbuster entertainment, IMAX is uniquely advantaged as theaters begin to reopen on a rolling basis throughout the world. Our model gives us the flexibility to reopen where safe, program locally relevant content to maximize revenues, and play a leadership role as the industry returns," said IMAX CEO Richard L. Gelfond. "We are seeing early signs of progress, with approximately 40% of our global network currently generating revenue. This includes 409 IMAX® theaters in China, which are scheduled to debut Hollywoodand local language films over the coming weeks. Additionally, the South Korean blockbuster "Peninsula" continues to perform well across markets in Asiaand Europe, drawing $26.5 millionin global box office despite capacity limitations and highlighting solid demand among moviegoers in lower-risk markets worldwide." "We believe that our solid financial position gives IMAX the strength to be ready as the rest of our network comes back online. At the end of the second quarter, the Company had $319 millionin consolidated cash and recently amended its credit agreement for increased financial flexibility through September 2021." "We continue to look ahead to an exceptionally strong slate through 2021, as studios affirm their commitment to the theatrical release by rescheduling their key blockbuster titles. Additionally, major global exhibitors continue to underscore the value of _The_IMAX _Experience_, with new agreements including a 10-theatre deal with Wanda Film in Chinaand a multinational 17-theatre deal with CGV." "We remain unwavering in our stance that the health and safety of audiences must be the priority as theaters reopen and we support by the work of local governments and our partners to put public health first." **Second Quarter and June Year-to-Date Segment Results**(1) **IMAX Technology Network** **IMAX Technology Sales and Maintenance** **Revenue** **(Margin Loss) Gross** **Margin** **(Margin Loss) Gross** **Margin %** **Revenue** **Gross** **Margin** **Gross** **Margin %** **2Q20** $ 0.4 $ (6.5) N/A $ 4.6 $ 0.2 4.9 % **2Q19** 64.8 43.3 66.8 % 34.8 15.4 44.1 % **% change** (99.4) % (115.1) % (86.8) % (98.5) % **YTD 2Q20** $ 17.0 $ (3.7) (21.8) % $ 19.7 $ 5.0 25.1 % **YTD 2Q19** 110.8 75.0 67.7 % 65.0 28.5 43.8 % **% change** (84.7) % (104.9) % (69.7) % (82.6) % (1)  Please refer to the Company's Form 10-Q for the period ended June 30, 2020for additional segment information **IMAX Technology Network** * IMAX Technology Network revenues decreased 99% to $0.4 millionin the second quarter of 2020, compared to $64.8 millionin the prior-year period. The closure of the Company's network due to the COVID-19 pandemic impacted results. * Margin (loss) for the IMAX Technology Network was ($6.5) millionin the second quarter of 2020 and was driven by the lack of revenue and ongoing fixed costs associated with our installed IMAX network. **IMAX Technology Sales and Maintenance** * IMAX Technology Sales and Maintenance revenues decreased 87% to $4.6 millionin the second quarter of 2020, compared with $34.8 millionin the prior year period. Seven fewer sales type lease installations principally resulted in lower IMAX system revenue. IMAX maintenance revenue declined to nil as regular maintenance services were suspended due to the COVID-19 theater closures. * Total gross margin for IMAX Technology Sales and Maintenance was $0.2 millioncompared to $15.4 millionin the prior year period. Lower revenue was partially offset by the shift in certain overhead costs from cost of sales to SG&A. **Cash Balances and Outstanding Debt** Total cash and cash equivalents as of June 30, 2020were $319 million. Total debt was $300.2 millionas of June 30, 2020. **Share Count and Capital Return** * The weighted average diluted shares outstanding at the end of the second quarter of 2020 declined 4.4% to 58.8 million, compared to 61.5 million in the second quarter of 2019, due primarily to share repurchase activity during the twelve-month period. During the second quarter of 2020, the Company did not repurchase any stock. A total of $89.4 millionremains available under the Company's outstanding share repurchase authorization, which was extended in June and now expires in June 2021. * During the second quarter of 2020, IMAX China repurchased a total of 423 thousand shares at an average price of $1.50for a total value of approximately $640 thousand. **Supplemental Materials** For more information about the Company's results, please refer to the IMAX Investor Relations website located at [investors.imax.com](https://c212.net/c/link/?t=0&l=en&o=2869702-1&h=1315211705&u=https%3A%2F%2Fwww.imax.com%2Fcontent%2Finvestor-relations&a=investors.imax.com). **Investor Relations Website and Social Media** On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at [investors.imax.com](https://c212.net/c/link/?t=0&l=en&o=2869702-1&h=1315211705&u=https%3A%2F%2Fwww.imax.com%2Fcontent%2Finvestor-relations&a=investors.imax.com). The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag. The information posted on the Company's corporate and Investor Relations website may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases, SECfilings and public conference calls and webcasts. **Conference Call** The Company will host a conference call today at 4:30PM ETto discuss its second quarter 2020 financial results. This call is being webcast by PGI and can be accessed at [investors.imax.com](https://c212.net/c/link/?t=0&l=en&o=2869702-1&h=1315211705&u=https%3A%2F%2Fwww.imax.com%2Fcontent%2Finvestor-relations&a=investors.imax.com). To access the call via telephone, interested parties in the US and Canadashould dial (800) 367-2403 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 490-5367. The conference ID for the call is 9071085. A replay of the call will be available via webcast at [investors.imax.com](https://c212.net/c/link/?t=0&l=en&o=2869702-1&h=1315211705&u=https%3A%2F%2Fwww.imax.com%2Fcontent%2Finvestor-relations&a=investors.imax.com)or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 9071085. **About IMAX Corporation**  IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe. IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of June 30, 2020, there were 1,615 IMAX theater systems (1,527 commercial multiplexes, 13 commercial destinations, 75 institutional) operating in 81 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchangeunder the stock code "HK.1970." IMAX®, IMAX® Dome, IMAX® 3D, IMAX® 3D Dome, Experience It In IMAX®, The IMAX Experience®, An IMAX Experience®, An IMAX 3D Experience®, IMAX DMR®, DMR®, IMAX nXos® and Films to the Fullest®, are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at [www.imax.com](http://www.imax.com). You may also connect with IMAX on Instagram ([https://www.instagram.com/imax](https://c212.net/c/link/?t=0&l=en&o=2869702-1&h=762665373&u=https%3A%2F%2Fwww.instagram.com%2Fimax&a=https%3A%2F%2Fwww.instagram.com%2Fimax)), Facebook ([www.facebook.com/imax](http://www.facebook.com/imax)), Twitter ([www.twitter.com/imax](http://www.twitter.com/imax)) and YouTube ([www.youtube.com/imaxmovies](https://c212.net/c/link/?t=0&l=en&o=2869702-1&h=152938764&u=http%3A%2F%2Fwww.youtube.com%2Fimaxmovies&a=www.youtube.com%2Fimaxmovies)). For additional information please contact: **_Investors: _**IMAX Corporation, New York Brett Harriss 212-821-0187 [bharriss@IMAX.com](mailto:bharriss@IMAX.com)  _**Media: **_IMAX Corporation, New York Mark Jafar 212-821-0102 [mjafar@imax.com](mailto:mjafar@imax.com)  **Forward****\-Looking Statements** _This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporationtogether with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United Statesand Canada; risks related to the Company's growth and operations in China; the performance of IMAX DMR__®__films; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company's inability to protect the Company's intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from any of the Company's restructuring initiatives; the impact of COVID-19 on our financial condition and results of operations and on the businesses of our customers and exhibitor partners;_ _and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q._ _The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise._ **Primary****Reporting Groups** The Company has the following reportable segments: (i) IMAX DMR; (ii) Joint Revenue Sharing Arrangements; (iii) IMAX Systems, (iv) IMAX Maintenance; (v) Other Theater Business; (vi) New Business Initiatives; (vii) Film Distribution; and (viii) Film Post\-production. The Company organizes its reportable segments into the following four categories, identified by the nature of the product sold or service provided: (i) IMAX Technology Network, which earns revenue based on contingent box office receipts and includes the IMAX DMR segment and contingent rent from the Joint Revenue Sharing Arrangement ("JRSA") segment; (ii) IMAX Technology Sales and Maintenance, which includes results from the IMAX Systems, IMAX Maintenance and Other Theater Business segments, as well as fixed revenues from the JRSA segment; (iii) New Business Initiatives, which is a segment that includes activities related to the exploration of new lines of business and new initiatives outside of the Company's core business; and (iv) Film Distribution and Post-production, which includes activities related to the licensing of film content, the distribution of films primarily for the Company's institutional theater partners (through the Film Distribution segment) and the provision of film post-production and quality control services (through the Film Post\-production segment). **Signings and Installations** **Three Months** **Ended June 30,** **Theater System Signings:** **2020** **2019** Full new sales and sales-type lease arrangements 12 7 New hybrid joint revenue sharing lease arrangements 17 45 New traditional joint revenue sharing arrangements \- 2 **Total new IMAX theaters** **29** **54** Upgrades of IMAX theater systems \- 19 **Total theater signings** **29** **73** **Three Months** **Ended June 30,** **Theater System Installations:** **2020** **2019** Full new sales and sales-type lease arrangements 2 9 New hybrid joint revenue sharing lease arrangements 1 5 New traditional joint revenue sharing arrangements \- 13 **Total new IMAX theaters** **3** **27** Upgrades of IMAX theater systems — 8 **Total theater installations** **3** **35** **Three Months** **Ended June 30,** **Theater Sales Backlog:** **2020** **2019** Sales and sales-type lease arrangements 190 182 Hybrid JRSA 154 154 Traditional JRSA 215 (1) 276 (1) **Total theater backlog** **559** (2) **612** (3) **Three Months** **Ended June 30,** **Theater Network:** **2020** **2019** Commercial Multiplex Theaters: Sales and sales-type lease arrangements 659 619 Hybrid joint revenue sharing lease arrangements 138 133 Traditional joint revenue sharing lease arrangements 730 693 **Total Commercial Multiplex Theaters(4)** **1,527** **1,445**  Commercial Destination Theaters 13 15  Institutional Theaters 75 81 **Total theater network** **1,615** **1,541** (1)   Includes 46 IMAX Theater Systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement (2019 — 60). (2)  Includes 154 new IMAX with Laser projection system configurations and 94 upgrades of existing locations to IMAX with Laser projection system configurations. (3)  Includes 139 new IMAX with Laser projection system configurations and 118 upgrades of existing locations to IMAX with Laser projection system configurations. (4)   Period to period changes are net of the effects of permanently closed theaters.           **IMAX CORPORATION** **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** _(In thousands of U.S.dollars, except per share amounts)_ **_(Unaudited)_** **Three Months Ended** **Six Months Ended** **June 30,** **June 30,** **2020** **2019** **2020** **2019** **Revenues** Technology sales $ 2,687 $ 19,694 $ 8,349 $ 34,894 Image enhancement and maintenance services 3,799 56,662 24,520 100,809 Technology rentals (137) 25,863 5,834 44,033 Finance income 2,506 2,578 5,054 5,259 **8,855** **104,797** **43,757** **184,995** **Costs and expenses applicable to revenues** Technology sales 2,546 11,939 6,415 21,374 Image enhancement and maintenance services 7,244 26,781 25,060 46,024 Technology rentals 6,753 6,524 14,884 12,904 **16,543** **45,244** **46,359** **80,302** **(Margin loss) gross margin** **(7,688)** **59,553** **(2,602)** **104,693** Selling, general and administrative expenses 29,796 32,136 58,432 59,785 Research and development 1,232 1,222 3,432 2,358 Amortization of intangibles 1,344 1,218 2,665 2,293 Credit loss expense 1,440 927 11,657 1,358 Asset impairments \- \- 1,151 \- Exit costs, restructuring charges and associated impairments \- \- \- 850 **(Loss) income from operations** **(41,500)** **24,050** **(79,939)** **38,049** Gain (loss) in fair value of equity investment 2,025 (4,544) (2,514) (2,053) Retirement benefits non-service expense (130) (160) (246) (320) Interest income 891 572 1,256 1,142 Interest expense (1,581) (636) (2,229) (1,317) **(Loss) income before taxes** **(40,295)** **19,282** **(83,672)** **35,501** Income tax benefit (expense) 10,248 (5,308) (5,257) (8,956) Equity in losses of investees, net of tax \- (138) (529) (222) **Net (loss) income** **(30,047)** **13,836** **(89,458)** **26,323** Less: Net loss (income) attributable to non-controlling interests 4,080 (2,439) 14,137 (6,661) **Net (loss) income attributable to common shareholders** **$** **(25,967)** **$** **11,397** **$** **(75,321)** **$** **19,662** **Net (loss) income per share attributable to common shareholders -** **basic and diluted:** Net (loss) income per share — basic and diluted **$** **(0.44)** **$** **0.19** **$** **(1.26)** **$** **0.32** Weighted average number of shares outstanding (000's): Basic 58,808 61,331 59,613 61,354 Fully Diluted 58,808 61,507 59,613 61,525 Additional Disclosure: Depreciation and amortization(1) $ 11,930 $ 15,593 $ 27,182 $ 29,804 (1)   Includes $0.2 millionand $0.3 millionof amortization of deferred financing costs charged to interest expense for the three months and six months ended June 30, 2020, respectively ($0.1 millionand $0.2 million, respectively). **IMAX CORPORATION**  **CONDENSED CONSOLIDATED BALANCE SHEETS** **In accordance with United States Generally Accepted Accounting Principles** _(In thousands of dollars, except share amounts)_ **_(Unaudited)_** **June 30,** **December 31,** **2020** **2019** **Assets** Cash and cash equivalents $ 318,986 $ 109,484 Accounts receivable, net of allowance for credit losses 54,839 99,513 Financing receivables, net of allowance for credit losses 123,865 128,038 Variable consideration receivable, net of allowance for credit losses 39,397 40,040 Inventories 60,179 42,989 Prepaid expenses 12,008 10,237 Film assets 13,147 17,921 Property, plant and equipment 287,220 306,849 Investment in equity securities 13,192 15,685 Other assets 24,575 25,034 Deferred income tax assets 46,826 23,905 Other intangible assets 28,204 30,347 Goodwill 39,027 39,027 **Total assets** **$** **1,061,465** **$** **889,069** **Liabilities** Bank indebtedness $ 297,765 $ 18,229 Accounts payable 13,668 20,414 Accrued and other liabilities 108,917 112,779 Deferred revenue 104,311 94,552 Deferred income tax liabilities 18,475 — **Total liabilities** **543,136** **245,974** **Commitments and contingencies** **Non-controlling interests** **4,237** **5,908** **Shareholders' equity** Capital stock common shares — no par value. Authorized — unlimited number. 58,878,749 issued and 58,857,436 outstanding (December 31, 2019— 61,362,872 issued and 61,175,852 outstanding) 405,583 423,386 Less: Treasurystock, 21,313 shares at cost (December 31, 2019— 187,020) (329) (4,038) Other equity 172,690 171,789 Accumulated deficit (134,395) (40,253) Accumulated other comprehensive loss (4,180) (3,190) **Total shareholders' equity attributable to common shareholders** **439,369** **547,694** Non-controlling interests 74,723 89,493 **Total shareholders' equity** **514,092** **637,187** **Total liabilities and shareholders' equity** **$** **1,061,465** **$** **889,069** **IMAX CORPORATION**  **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** _(In thousands of dollars)_ **_(Unaudited)_** **Six Months Ended** **June 30,** **2020** **2019** **Cash (used in) provided by:** **Operating Activities** Net (loss) income $ (89,458) $ 26,323 Adjustments to reconcile net (loss) income to cash from operating activities: Depreciation and amortization 27,182 29,804 Credit loss expense 11,657 1,358 Write-downs 6,806 508 Deferred income tax (benefit) expense (4,878) 1,296 Share-based and other non-cash compensation 10,850 11,710 Unrealized foreign currency exchange loss (gain) 312 (14) Loss in fair value of equity securities 2,514 2,053 Equity in losses of investees 529 222 Changes in assets and liabilities: Accounts receivable 36,971 489 Inventories (16,887) (3,226) Film Assets (4,057) (8,214) Deferred revenue 9,799 (1,355) Changes in other operating assets and liabilities (12,220) (12,437) **Net cash (used in) provided by operating activities** **(20,880)** **48,517** **Investing Activities** Purchase of property, plant and equipment (594) (4,175) Purchase of equipment for joint revenue sharing arrangements (3,908) (22,235) Acquisition of other intangible assets (1,221) (1,121) Investment in equity securities — (15,153) **Net cash used in investing activities** **(5,723)** **(42,684)** **Financing Activities** Increase in credit facility borrowings 280,244 35,000 Repayment of credit facility borrowings — (50,000) Credit facility amendment fees paid (959) — Settlement of restricted share units and options (2,757) (7,619) Treasurystock repurchased for future settlement of restricted share units (329) (1,575) Repurchase of common shares, IMAX China (1,532) (16,813) Taxes withheld and paid on employee stock awards vested (251) (219) Common shares issued - stock options exercised — 2,379 Repurchase of common shares (36,624) (1,258) Issuance of subsidiary shares to non-controlling interests (net of return on capital) — 1,106 Dividends paid to non-controlling interests (2,118) (2,266) **Net cash provided by (used in) financing activities** **235,674** **(41,265)** Effects of exchange rate changes on cash 431 293 **Increase (decrease) in cash and cash equivalents during period** **209,502** **(35,139)** **Cash and cash equivalents, beginning of period** **109,484** **141,590** **Cash and cash equivalents, end of period** **$** **318,986** **$** **106,451** **Three Months Ended** **Six Months Ended** **June 30,** **June 30,** **2020** **2019** **2020** **2019** **Revenue** IMAX Technology Network IMAX DMR $ 546 $ 39,293 $ 11,175 $ 67,243 Joint revenue sharing arrangements, contingent rent(2) (137) 25,540 5,834 43,584 409 64,833 17,009 110,827 IMAX Technology Sales and Maintenance IMAX Systems 4,549 16,501 10,237 29,527 Joint revenue sharing arrangements, fixed fees 369 2,548 1,139 5,087 IMAX Maintenance — 13,207 7,370 26,158 Other Theater Business(3) (309) 2,580 954 4,206 4,609 34,836 19,700 64,978 New Business Initiatives 632 478 1,110 1,312 Film Distribution and Post-production 3,182 3,601 5,676 6,263 8,832 103,748 43,495 183,380 Other 23 1,049 262 1,615 Total revenues $ 8,855 $ 104,797 $ 43,757 $ 184,995 **(Margin Loss) Gross Margin** IMAX Technology Network IMAX DMR(1) $ (30) $ 23,961 $ 4,413 $ 43,736 Joint revenue sharing arrangements, contingent rent(1) (6,501) 19,318 (8,119) 31,253 (6,531) 43,279 (3,706) 74,989 IMAX Technology Sales and Maintenance IMAX Systems (1) 2,650 8,019 5,826 15,071 Joint revenue sharing arrangements, fixed fees(1) 48 870 227 1,165 IMAX Maintenance (1,908) 5,640 (1,149) 10,921 Other Theater Business (564) 841 46 1,316 226 15,370 4,950 28,473 New Business Initiatives 512 281 873 900 Film Distribution and Post-production (1) (1,396) 458 (3,331) 433 (7,189) 59,388 (1,214) 104,795 Other (499) 165 (1,388) (102) Total Segment Margin $ (7,688) $ 59,553 $ (2,602) $ 104,693 **\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_** (1)   IMAX DMR gross margin includes marketing expense of $nil and $2.4million for the three and six months ended June 30, 2020, respectively (2019 — $9.5million and $13.4 million, respectively). JRSA gross margin includes advertising, marketing and commission expense of less than $0.1 millionand $0.6million for the three and six months ended June 30, 2020, respectively (2019 —$0.2 million and $0.3 million, respectively). IMAX Systems gross margin includes marketing and commission costs of $0.2million and $0.4million for the three and six months ended June 30, 2020, respectively, (2019 — $0.4million and $0.9 million, respectively). Film Distribution segment gross margin includes marketing expense of $nil and $0.2million for the three and six months ended June 30, 2020, respectively (2019 — less than $0.1million and $0.6 million, respectively). (2)   The Company is reporting negative revenue due to the continued amortization of lessee incentives that are typically netted against lease revenues, which are abnormally low during the period due to the COVID-19 global pandemic. (3)   The Company is reporting negative revenue due to an adjustment to prior period revenue. **IMAX CORPORATION ****OTHER INFORMATION **_(in thousands of U.S.dollars)_ **_Non-GAAP Financial Measures:_** In this release, the Company presents adjusted net (loss) income attributable to common shareholders and adjusted net (loss) income attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, and free cash flow as supplemental measures of the Company's performance, which are not recognized under U.S.GAAP. Adjusted net (loss) income attributable to common shareholders and adjusted net (loss) income attributable to common shareholders per diluted share exclude, where applicable: (i) share-based compensation; (ii) exit costs, restructuring charges and associated impairments, (iii) changes in the fair value of equity investments, (iv) COVID-19 government relief benefits, as well as the related tax impact of these adjustments, and (v) the income tax effects related to the removal of the indefinitely reinvested assertion on the historical earnings of certain subsidiaries. The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net (loss) income attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures. In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Credit Agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its Credit Agreement requirements in the current period, if applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results. EBITDA is defined as net (loss) income excluding (i) interest expense, net of interest income; (ii) income tax (benefit) expense; and (iii) depreciation and amortization, including film asset amortization. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) gain (loss) in fair value of equity investment; (iii) write-downs, net of recoveries, including asset impairments and credit loss expense; (iv) gain (loss) from equity accounted investment; (v) exit costs, restructuring charges and associated impairments; (vi) legal arbitration award; and (vii) executive transition costs. Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the condensed consolidated statements of cash flows). Cash provided by operating activities consist of net (loss) income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below. These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts. A reconciliation of each of these non-GAAP measures to the most directly comparable GAAP measures is presented below. **For the Three Months Ended June 30, 2020** **For the Three Months Ended June 30, 2019** **Attributable to** **Non-controlling** **Less:** **Attributable to** **Non-controlling** **Less:** **Interests and** **Attributable to** **Attributable to** **Interests and** **Attributable to** **Attributable to** **Common** **Non-controlling** **Common** **Common** **Non-controlling** **Common** **Shareholders** **Interests** **Shareholders** **Shareholders** **Interests** **Shareholders** **_(In thousands of U.S.Dollars)_** Reported net loss $ (30,047) $ (4,080) $ (25,967) $ 13,836 $ 2,439 $ 11,397 Add (subtract): Income tax (benefit) expense (10,248) 638 (10,886) 5,308 1,187 4,121 Interest expense, net of interest income 524 (96) 620 64 (140) 204 Depreciation and amortization, including film asset amortization 11,930 1,049 10,881 15,593 1,177 14,416 EBITDA $ (27,841) $ (2,489) $ (25,352) $ 34,801 $ 4,663 $ 30,138 Share-based and other non-cash compensation 6,541 299 6,242 7,186 228 6,958 (Gain) Loss in fair value of equity investment (2,025) (612) (1,413) 4,544 1,443 3,101 Write-downs, including asset impairments and credit loss expense 3,843 1,815 2,028 1,169 84 1,085 Loss from equity accounted investments — — — 138 — 138 Adjusted EBITDA per Credit Facility $ (19,482) $ (987) $ (18,495) $ 47,838 $ 6,418 $ 41,420 Revenues attributable to common shareholders(2) 8,855 421 8,434 104,797 10,216 94,581 Adjusted EBITDA margin attributable to common shareholders (220.0) % (234.7) % (219.3) % 45.6 % 62.8 % 43.8 % **For the Twelve Months Ended June 30, 2020 (1)** **For the Twelve Months Ended June 30, 2019 (1)** **Attributable to** **Non-controlling** **Less:** **Attributable to** **Non-controlling** **Less:** **Interests and** **Attributable to** **Attributable to** **Interests and** **Attributable to** **Attributable to** **Common** **Non-controlling** **Common** **Common** **Non-controlling** **Common** **Shareholders** **Interests** **Shareholders** **Shareholders** **Interests** **Shareholders** **_(In thousands of U.S.Dollars)_** Reported net loss $ (57,210) $ (9,093) $ (48,117) $ 37,596 $ 11,220 $ 26,376 Add (subtract): Income tax expense 13,069 6,707 6,362 10,386 3,737 6,649 Interest expense, net of interest income 922 (424) 1,346 392 63 329 Depreciation and amortization, including film asset amortization 60,865 4,897 55,968 59,207 5,372 53,835 EBITDA $ 17,646 $ 2,087 $ 15,559 $ 107,581 $ 20,392 $ 87,189 Share-based and other non-cash compensation 22,710 730 21,980 23,513 527 22,986 Loss in fair value of equity investment 978 274 704 2,053 652 1,401 Write-downs, including asset impairments and credit loss expense 23,404 5,420 17,984 5,518 1,827 3,691 Loss from equity accounted investments 304 — 304 409 — 409 Exit costs, restructuring charges and associated impairments — — — 9,234 — 9,234 Legal arbitration award — — — 4,237 — 4,237 Executive transition costs — — — 2,994 — 2,994 Adjusted EBITDA per Credit Facility $ 65,042 $ 8,511 $ 56,531 $ 155,539 $ 23,398 $ 132,141 Revenues attributable to common shareholders(2) 254,426 21,697 232,729 376,067 39,905 336,162 Adjusted EBITDA margin attributable to common shareholders 25.6 % 39.2 % 24.3 % 41.4 % 58.6 % 39.3 % \_\_\_\_\_\_\_\_\_\_\_\_\_ (1) Senior Secured Net Leverage Ratio calculated using twelve months ended Adjusted EBITDA per Credit Facility. During the second quarter, the Company entered into the Amendment to the Credit Facility Agreement which provides for, among other things, the suspension of the Senior Secured Net Leverage Ratio financial covenant through the first quarter of 2021. (2) **Three months ended June 30, 2020** **Three months ended June 30, 2019** **12 months ended June 30, 2020** **12 months ended June 30, 2019** Total revenues $ 8,855 $ 104,797 $ 254,426 $ 376,067 Greater Chinarevenues $ 1,393 $ 32,575 $ 71,700 $ 125,289 Non-controlling interest ownership percentage(3) 30.19 % 31.36 % 30.26 % 31.85 % Deduction for non-controlling interest share of revenues (421) (10,216) (21,697) (39,905) Revenues attributable to common shareholders $ 8,434 $ 94,581 $ 232,729 $ 336,162 (3) Weighted average ownership percentage for change in non-controlling interest share **IMAX CORPORATION** **Adjusted Net (Loss) Income Attributable to Common Shareholders and Adjusted Diluted Per Share Calculations** _(In thousands of U.S.dollars)_ _(Unaudited)_ **Three Months Ended** **Three Months Ended** **June 30, 2020** **June 30, 2019** **_(In thousands of U.S.dollars, except per share amounts)_** **Net Loss** **Diluted EPS** **Net Income** **Diluted EPS** Reported net (loss) income attributable to common shareholders $ (25,967) $ (0.44) $ 11,397 $ 0.19 Adjustments(1): Share-based compensation 6,168 0.10 $ 6,799 0.11 Change in the fair value of equity securities (1,413) (0.02) 3,101 0.05 COVID-19 government relief benefits (3,151) (0.05) — — Tax Impact on items listed above (857) (0.01) (1,604) (0.03) Income tax effects related to the removal of the indefinitely reinvested assertion on the historical earnings of certain subsidiaries (841) (0.02) — — Adjusted net (loss) income(1) $ (26,061) $ (0.44) $ 19,693 $ 0.32 Weighted average basic shares outstanding 58,808 61,331 Weighted average diluted shares outstanding 58,808 61,507 (1) Reflects amounts attributable to non-controlling interests. **Six Months Ended** **Six Months Ended** **June 30, 2020** **June 30, 2019** **_(In thousands of U.S.dollars, except per share amounts)_** **Net Income** **Diluted EPS** **Net Income** **Diluted EPS** Reported net (loss) income attributable to common shareholders $ (75,321) $ (1.26) $ 19,662 $ 0.32 Adjustments(1): Share-based compensation 10,243 0.17 $ 11,076 0.18 Exit costs, restructuring charges and associated impairments — — 850 0.01 Change in the fair value of equity securities 1,752 0.03 1,401 0.03 COVID-19 government relief benefits (3,151) (0.05) — — Tax impact on items listed above (1,195) (0.02) (2,484) (0.04) Income tax effects related to the removal of the indefinitely reinvested assertion on the historical earnings of certain subsidiaries 12,885 0.21 — — Adjusted net (loss) income(1) $ (54,787) $ (0.92) $ 30,505 $ 0.50 Weighted average basic shares outstanding 59,613 61,354 Weighted average diluted shares outstanding 59,613 61,525 (1) Reflects amounts attributable to non-controlling interests. **_Free Cash Flow:_** **Three Months Ended** **Six Months Ended** **June 30, 2020** **June 30, 2020** Net cash used in operating activities $ (26,846) $ (20,880) Net cash used in investing activities (3,010) (5,723) Free cash flow $ (29,856) $ (26,603) ![Cision](https://c212.net/c/img/favicon.png?sn=NY75917&sd=2020-07-28 "Cision")View original content to download multimedia:[http://www.prnewswire.com/news-releases/imax-corporation-reports-second-quarter-2020-results-301101555.html](http://www.prnewswire.com/news-releases/imax-corporation-reports-second-quarter-2020-results-301101555.html) SOURCE IMAX Corporation